Navigation Links
Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
Date:1/5/2009

Help us, help the Red Cross meet the winter demand for blood. January 30th noon to 5PM in our new Hyundai Dealer showroom at 271 Main St. Wilmington MA. We'll give you FREE oil change if you're one of the first 50 to donate blood.

Wilmington, MA (PRWEB) January 5, 2009 -- Bill Dube and the American Red Cross are asking people to come out and give blood as the recent ice & snow storms that hit New England have canceled blood drives.

Susan Parmer of the Northern New England Region of the Red Cross' blood services, says more than 500 units of blood expected this month have been lost and additional losses are anticipated. Potential donors must be at least 17, weigh at least 110 pounds and be in good health. Donors can give blood every eight weeks.

To make an appointment to give blood, or find a Red Cross blood drive, call (800) GIVE-LIFE or visit the Web site www.newenglandblood.org.

ABOUT RED CROSS
About 4 million people in the United States need a blood transfusion each year. That's one person every two seconds, and the overwhelming majority would die without it. There is no substitute for blood; volunteer donors are the only source. Blood is needed for emergencies, surgeries, and for people who have cancer, blood disorders and other illnesses. It is safe to give blood every 56 days. Visit www.givelife.org (sponsor code: "landrover") today to schedule an appointment at the nearest Red Cross blood donation center or to sponsor a blood drive at your job, school, place of worship or other appropriate loc
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. BMC, Boston University School of Medicine dermatologist named one of Americas Top Doctors
2. BMC, Boston University School of Medicine cardiologist named 1 of Americas Top Doctors
3. Boston University Medical Center gynecologist named one of Americas top doctors
4. Boston University Medical Center gastroenterologist
5. Boston University Medical Center nephrologist named one of Americas top doctors
6. Boston University School of Medicine receives a grant to study chronic obstructive pulmonary disease
7. Nyer Medical Group, Inc. Announces Pharmacy Service Agreement with East Boston Neighborhood Health Center
8. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
9. Former NBA and Boston Celtic Star Dee Brown Joins PrimeTime Sports, Boca Ratons Unique Sports Training Facility
10. Award-Winning Raw Food Documentarian to Screen Supercharge Me! in Boston
11. Premier Radiation Oncology Meeting Breaks Attendance, Exhibit Space Record at Boston Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
(Date:7/3/2009)... July 3 Bertalan Mesko, medical bl...e e-guide for medical professionals focusing on ...dical conferences are expensive and patients are a...is eGuide helps doctors enter a virtual realm and ...ee as Second Life provides opportunities for case ...
(Date:7/3/2009)... Republicans on the Sen...health care reform legislation that would eliminat... many women could lose coverage for abortion servi...s. Plus, millions of uninsured women will still la... promised a better quality of life. , , If thes...
(Date:7/3/2009)... ReverseAges.com launches new content to includ...atigue, and how to best deal with these health iss...EB) July 3, 2009 -- ReverseAges.com has recently l... the dangers of common health issues such as high ... variety of factors, and the new content on Revers...
(Date:7/2/2009)...ore,s Bioprocessing Technology Institute (BTI) hav...apoptosis inhibitory molecule" (FAIM), protects bo...ammed cell death. , Their research is published...ation . , The scientists, Jianxin Huo, Ph.D., an...cess may possibly be manipulated for clinical appl...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2
...that practitioners don’t have to use a lot of forc...ponse // as the body has its own energy or "biomag... system. That field can be altered by acupuncture ...opathy, massage, and even by the therapists' own p...
...e might be another use for cell phones that come c...ations.// Swiss researchers who used the phone cam...remote locations say doctors felt fairly comfortab...s. The study involved 52 patients with 61 chronic ...
...tudy researchers say a three-day regimen of the an...t as effective // as ciprofloxacin (Cipro) at trea...The most common bacterial infections for women are...tions. Treating the problem has become increasingl...
... now that after delivery depressions, that had pla... due to the trauma of the delivery. As a result of...ned caesarian birth to avoid the depression. A new... British Medical Journal says that this may not be...
Other Medicine News:
(Date:6/30/2009)...., June 30 Cephalon, Inc...bmitted a supplemental New Drug Application (sNDA)...questing approval of NUVIGIL(R) (armodafinil) Tabl...ess in patients with excessive sleepiness associat...travel. Jet lag disorder is an acute condition th...
(Date:6/29/2009)...ajor abdominal surgery patients achieved primary a..., June 29 AcelRx Pharmaceuticals, ...ond Phase 2 clinical study evaluating the safety a...for the management of acute post-operative pain in...alization. Compared to placebo, patients receiving...
(Date:6/28/2009)...NHAM, England and TOKYO, June 29 ,... Companies , Sosei Group Corporation ("Sose...c ("Vectura"; LSE: VEC) announce the commencement ...VA237, a once-daily, long-acting muscarinic,antag...ive pulmonary disease,(COPD). NVA237 is a dry pow...
(Date:6/26/2009)...pinion Recommends Approval of New Anti-TNF Therapy...TM) Autoinjector , , HORSHAM, Pa. and KENILWORT...r Ortho Biotech Inc. and Schering-Plough Corporati...ee for Medicinal Products for Human Use (CHMP) of ...itive opinion recommending the approval of SIMPONI...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 1Vermont Surgeon Implants First Accommodating Crystalens in Russia 9146 2PLC Systems Updates Common Stock Listing Status 29620 1PLC Systems Updates Common Stock Listing Status 29620 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 1Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 2Soft Contact Lenses Do Not Lead to Myopic Creep in Children Study Shows 3438 3Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 1Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures 29614 2
...Investigational cancer drug Pertuzumab shows promi...ed with Herceptin Phase III,development initiated,...esults from,Roche,s trial of the exciting new canc...or, show substantial anti-tumour activity in,patie...when,combined with Herceptin. The study showed tha...
...- First Agent Ever to Demonstrate Significant Surv...2007 /PRNewswire-FirstCall/ -- Bayer,HealthCare Ph...today announced that Nexavar(R) (sorafenib) tablet...nts with hepatocellular carcinoma,(HCC), or primar...(HR=0.69; p-value=0.0006). Results were presented ...
Other Medicine Technology:Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7
Double round silicone drain with trocar, 49 in. long, with 12.25 in. (30.5 cm) hole pattern
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Used for cholangiography and bile stone removal using fluoroscopy. Dual lumen catheter design allows concomitant fluoroscopic biliary imaging and wire basket placement for stone extraction. Supplied
Medicine Products: